Regression analysis of survival data in cancer chemotherapy / by 245294 Carter, Walter H., Wampler, Galen L., Stablein, M.

Crystal structure of (1R,3R)-8-benzyloxy-N-benzyl-6-hydroxy-1,3-dimethyl-l,2,3,4-tetrahydroisoquinolinehydrobromide,C9H6N(CH3)2(CH2C6H5)(OH)(OCH2C6H5)·HBr by Peters E.-M., Peters K., Walter R., Stäblein M., Bringmann G.

Get full text

Radiation protection measurement / by 202880 Kiefer, Hans, Maushart, Rupprecht, Ehret, R., Feshbach, Herman, Piesch, E., Stablein, M.

The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial by Kingslake, J, Dias, R, Dawson, G, Simon, J, Goodwin, G, Harmer, C, Morriss, R, Brown, S, Guo, B, Ruhe, H, Lever, A, Veltman, D, van Schaik, A, Deckert, J, Reif, A, Stablein, M, Menke, A, Gorwood, P, Voegeli, G, Perez, V, Browning, M

When a test is more than just a test: findings from patient interviews and survey in the trial of a technology to measure antidepressant medication response (the PReDicT Trial) by Brown, S, Ploeger, C, Guo, B, Petersen, JJ, Beckenstrom, AC, Browning, M, Dawson, GR, Deckert, J, Dias, R, Dourish, CT, Gorwood, P, Kingslake, J, Menke, A, Sola, VP, Reif, A, Ruhe, H, Simon, J, Stäblein, M, van Schaik, A, Veltman, DJ, Morriss, R, PReDicT Group

The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial by Browning, M, Bilderbeck, A, Dias, R, Dourish, C, Kingslake, J, Deckert, J, Goodwin, G, Gorwood, P, Guo, B, Harmer, C, Morriss, R, Reif, A, Ruhe, H, van Chaik, A, Simon, J, Perez Sola, V, Veltman, D, Elices, M, Lever, A, Menke, A, Scanferla, E, Stablein, M, Dawson, G